151 related articles for article (PubMed ID: 27380733)
1. Dynamic Contrast-enhanced MR Imaging in Renal Cell Carcinoma: Reproducibility of Histogram Analysis on Pharmacokinetic Parameters.
Wang HY; Su ZH; Xu X; Sun ZP; Duan FX; Song YY; Li L; Wang YW; Ma X; Guo AT; Ma L; Ye HY
Sci Rep; 2016 Jul; 6():29146. PubMed ID: 27380733
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility of Dynamic Contrast-Enhanced MRI in Renal Cell Carcinoma: A Prospective Analysis on Intra- and Interobserver and Scan-Rescan Performance of Pharmacokinetic Parameters.
Wang H; Su Z; Ye H; Xu X; Sun Z; Li L; Duan F; Song Y; Lambrou T; Ma L
Medicine (Baltimore); 2015 Sep; 94(37):e1529. PubMed ID: 26376399
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.
Beuzit L; Eliat PA; Brun V; Ferré JC; Gandon Y; Bannier E; Saint-Jalmes H
J Magn Reson Imaging; 2016 Jun; 43(6):1288-300. PubMed ID: 26687041
[TBL] [Abstract][Full Text] [Related]
4. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
[TBL] [Abstract][Full Text] [Related]
5. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
[TBL] [Abstract][Full Text] [Related]
6. Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis.
Chen YL; Li R; Chen TW; Ou J; Zhang XM; Chen F; Wu L; Jiang Y; Laws M; Shah K; Joseph B; Hu J
Eur J Radiol; 2019 Mar; 112():112-120. PubMed ID: 30777199
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
8. Application of Dynamic Contrast-Enhanced MRI Parameters for Differentiating Squamous Cell Carcinoma and Malignant Lymphoma of the Oropharynx.
Park M; Kim J; Choi YS; Lee SK; Koh YW; Kim SH; Choi EC
AJR Am J Roentgenol; 2016 Feb; 206(2):401-7. PubMed ID: 26797371
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
[TBL] [Abstract][Full Text] [Related]
10. Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma.
Reynolds HM; Parameswaran BK; Finnegan ME; Roettger D; Lau E; Kron T; Shaw M; Chander S; Siva S
PLoS One; 2018; 13(8):e0202387. PubMed ID: 30114235
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Histogram Analysis of DCE-MRI Parameters on Differentiating Renal Tumors.
Li H; Zhao S; Fan HY; Li Y; Wu XP; Miao YP
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948477
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced MR imaging of the rectum: Correlations between single-section and whole-tumor histogram analyses.
Choi MH; Oh SN; Park GE; Yeo DM; Jung SE
Diagn Interv Imaging; 2018 Sep; 99(9):537-545. PubMed ID: 29754871
[TBL] [Abstract][Full Text] [Related]
13. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma.
Yang JF; Zhao ZH; Zhang Y; Zhao L; Yang LM; Zhang MM; Wang BY; Wang T; Lu BC
World J Gastroenterol; 2016 Apr; 22(13):3652-62. PubMed ID: 27053857
[TBL] [Abstract][Full Text] [Related]
14. High temporal resolution 3D gadolinium-enhanced dynamic MR imaging of renal tumors with pharmacokinetic modeling: preliminary observations.
Chandarana H; Amarosa A; Huang WC; Kang SK; Taneja S; Melamed J; Kim S
J Magn Reson Imaging; 2013 Oct; 38(4):802-8. PubMed ID: 23389833
[TBL] [Abstract][Full Text] [Related]
15. Suitability of pharmacokinetic models for dynamic contrast-enhanced MRI of abdominal aortic aneurysm vessel wall: a comparison.
Nguyen VL; Kooi ME; Backes WH; van Hoof RH; Saris AE; Wishaupt MC; Hellenthal FA; van der Geest RJ; Kessels AG; Schurink GW; Leiner T
PLoS One; 2013; 8(10):e75173. PubMed ID: 24098370
[TBL] [Abstract][Full Text] [Related]
16. Dynamic fractal signature dissimilarity analysis for therapeutic response assessment using dynamic contrast-enhanced MRI.
Wang C; Subashi E; Yin FF; Chang Z
Med Phys; 2016 Mar; 43(3):1335-47. PubMed ID: 26936718
[TBL] [Abstract][Full Text] [Related]
17. Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
Sun NN; Ge XL; Liu XS; Xu LL
Radiol Med; 2020 Feb; 125(2):165-176. PubMed ID: 31605354
[TBL] [Abstract][Full Text] [Related]
18. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
19. Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
Spanakis M; Kontopodis E; Van Cauter S; Sakkalis V; Marias K
J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):529-47. PubMed ID: 27647272
[TBL] [Abstract][Full Text] [Related]
20. Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging.
Jeon TY; Kim CK; Kim JH; Im GH; Park BK; Lee JH
Br J Radiol; 2015 Sep; 88(1053):20150163. PubMed ID: 26133222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
